Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Kraig Biocraft Laboratories, Inc. (KBLB)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0695-0.0005 (-0.71%)
At close: 03:51PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.0700
Open0.0680
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0675 - 0.0695
52 Week Range0.0600 - 0.1500
Volume382,841
Avg. Volume784,137
Market Cap66.549M
Beta (5Y Monthly)-0.13
PE Ratio (TTM)N/A
EPS (TTM)-0.0090
Earnings DateAug 10, 2022 - Aug 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for KBLB

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • KRAIG BIOCRAFT LABORATORIES INC
    Daily – Vickers Top Buyers & Sellers for 07/12/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    10 months agoArgus Research
View more
  • GlobeNewswire

    Kraig Biocraft Laboratories Enters Biomedical Field with First Sample Shipments of Fibers and Fabrics for Tissue Engineering

    ANN ARBOR, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercialization of spider silk, announces the first sample shipment of its recombinant spider silk fibers and fabrics for use and evaluation into a range of biomedical applications. This shipment was made in response to the significant increase in the requests for its propriety spider silk technology, over the l

  • GlobeNewswire

    Kraig Biocraft Laboratories Strengthens Q2 Spider Silk Production Expansion with New Vendor Quality Assurance Program

    ANN ARBOR, Mich., May 03, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercialization of spider silk, announces that it has strengthened its second-quarter production expansion with a new vendor quality assurance program. This new program will allow the Company to screen numerous mulberry suppliers and grow its database of trusted vendors. This new vendor verification program was

  • GlobeNewswire

    Kraig Biocraft Laboratories Kicks Off Q2 Recombinant Spider Silk Production as Lab Increases Testing Throughput Nearly Ten Fold

    ANN ARBOR, Mich., April 27, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces that it has kicked off the first production run of the second quarter for its recombinant spider silk. In support of the growing production capacity at the Company’s subsidiary, Prodigy Textiles, the laboratory team has dramatically increased the testing throughput. Th

Advertisement
Advertisement